Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies-Reference-Cited by-同舟云学术

Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies

Published:2022-10-15 Issue: Volume: Page:
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Thomas Austin R.,Eyada Mostafa,Kono Miho,Varatharajalu Krishnavathana,Lu Yang,Xu Guofan,Panneerselvam Kavea,Shatila Malek,Altan Mehmet,Wang Jennifer,Thompson John A.,Zhang Hao Chi,Khan Muhammad Ali,Raju Gottumukkala S.,Thomas Anusha S.,Wang Yinghong

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04405-3.pdf

Reference49 articles.

1. Abu-Sbeih H, Ali F, Naqash A, Owen D, Patel S, Otterson G et al (2019a) Resumption of immune checkpoint inhibitor therapy after immune-mediated colitis. J Clin Oncol 37(30):2738–2745

2. Abu-Sbeih H, Ali F, Qiao W, Lu Y, Patel S, Diab A et al (2019b) Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma. Cancer Immunol Immunother 68(4):553–561

3. Alonso S, Pera M, Parés D, Pascual M, Gil M, Courtier R et al (2010) Outpatient treatment of patients with uncomplicated acute diverticulitis. Colorectal Dis 12(10 Online):e278-282

4. Bahadursingh A, Virgo K, Kaminski D, Longo W (2003) Spectrum of disease and outcome of complicated diverticular disease. Am J Surg 186(6):696–701

5. Barina A, Bashir M, Howard B, Hanks B, Salama A, Jaffe T (2016) Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis. Abdom Radiol (NY) 41(2):207–214

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Checkpoint Inhibitor-Induced Colitis: An Update;Biomedicines;2023-05-22